Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717651 · ClinicalTrials.gov registry record
Muscle Atrophy in Patients With Severe Sepsis
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 25
- Enrollment target
NCT01717651 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 25 participants.
The verdict
NCT01717651 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study is being done to help determine whether patients with severe sepsis (overwhelming inflammation in the body as a result of an infection) lose muscle and become weak more rapidly than patients with other severe illnesses. Weakness and muscle loss that develops after a severe illness is a serious problem. Patients who develop weakness and have a decrease in muscle size often have to stay in the hospital longer and have a higher chance of dying. At the current time, it is not clear whether certain severe illnesses are more likely to cause weakness and muscle loss. This study will be done to measure the changes in muscle size and strength as a result of each patient's illness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01717651
The ClinicalTrials.gov registry entry for NCT01717651 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01717651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01717651 about?
NCT01717651 is a clinical study titled "Muscle Atrophy in Patients With Severe Sepsis". This study is being done to help determine whether patients with severe sepsis (overwhelming inflammation in the body as a result of an infection) lose muscle and become weak more rapidly than patients with other severe illnesses. Weakness and muscle loss that develops after a severe illness is a se...
What is the current status of trial NCT01717651?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2011-12. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01717651?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.